Correlation Between GlaxoSmithKline PLC and SPDR Barclays
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and SPDR Barclays at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and SPDR Barclays into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and SPDR Barclays Euro, you can compare the effects of market volatilities on GlaxoSmithKline PLC and SPDR Barclays and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of SPDR Barclays. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and SPDR Barclays.
Diversification Opportunities for GlaxoSmithKline PLC and SPDR Barclays
-0.81 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between GlaxoSmithKline and SPDR is -0.81. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and SPDR Barclays Euro in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SPDR Barclays Euro and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with SPDR Barclays. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SPDR Barclays Euro has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and SPDR Barclays go up and down completely randomly.
Pair Corralation between GlaxoSmithKline PLC and SPDR Barclays
Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the SPDR Barclays. In addition to that, GlaxoSmithKline PLC is 8.71 times more volatile than SPDR Barclays Euro. It trades about -0.24 of its total potential returns per unit of risk. SPDR Barclays Euro is currently generating about 0.1 per unit of volatility. If you would invest 5,356 in SPDR Barclays Euro on August 28, 2024 and sell it today you would earn a total of 43.00 from holding SPDR Barclays Euro or generate 0.8% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
GlaxoSmithKline PLC ADR vs. SPDR Barclays Euro
Performance |
| Timeline |
| GlaxoSmithKline PLC ADR |
| SPDR Barclays Euro |
GlaxoSmithKline PLC and SPDR Barclays Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GlaxoSmithKline PLC and SPDR Barclays
The main advantage of trading using opposite GlaxoSmithKline PLC and SPDR Barclays positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, SPDR Barclays can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SPDR Barclays will offset losses from the drop in SPDR Barclays' long position.| GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
| SPDR Barclays vs. Leverage Shares 3x | SPDR Barclays vs. Leverage Shares 3x | SPDR Barclays vs. Leverage Shares 3x | SPDR Barclays vs. WisdomTree Short GBP |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |